Glucagon Kit
Product Images NDC 70748-311

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 70748-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 01)

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 01)
Chemical structure of the peptide hormone glucagon, represented as a linear chain of amino acid residues labeled with their standard three-letter codes from Histidine (His) at position 1 to Threonine (Thr) at position 29.*
FDA Label Image

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 02)

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 02)
A line graph depicting blood glucose concentrations (mg/dL) over time (hours) from 0 to 4 hours. The graph shows an initial increase in blood glucose levels reaching a peak around 0.5 hours, followed by a gradual decline and stabilization between 1.5 and 4 hours. Error bars indicate variability at each time point.*
FDA Label Image

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 03)

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 03)
A pharmacokinetic curve showing glucagon concentration (ng/mL) over time (hours). The graph depicts an initial rapid increase in glucagon levels reaching a peak between 0.25 and 0.5 hours, followed by a gradual decline over the subsequent hours, approaching near zero by 4 hours.*
FDA Label Image

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 04)

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 04)
An instructional diagram showing components of the GLUCAGON kit by Lupin Pharmaceuticals, Inc. It labels the vial containing powder with rubber stopper and flip-off seal, a needle protector, and a prefilled syringe containing diluent with attached needle, backstop and plastic clip, and plunger. The figure is labeled as Figure A.*
FDA Label Image

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 05)

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 05)
An instructional illustration showing a human hand holding an ampule with the thumb and fingers, with an arrow pointing upward, indicating the direction to snap or break the ampule tip for use.*
FDA Label Image

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 06)

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 06)
An instructional illustration labeled Figure C showing hands holding a vial and a syringe. The diagram demonstrates the action of inserting the syringe needle into the vial, indicated by a black arrow pointing downward on the syringe plunger. This image is likely part of preparation instructions for the Glucagon kit by Lupin Pharmaceuticals, Inc.*
FDA Label Image

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 07)

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 07)
An instructional illustration labeled Figure D shows a hand holding a small vial or container, rotating it in a circular motion to mix or dissolve its contents. This diagram appears to be part of usage instructions for the GLUCAGON kit by Lupin Pharmaceuticals.*
FDA Label Image

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 08)

Image (8b4c72aa 10a8 4242 93bf E067d6d56f9a 08)
An instructional illustration showing the hands holding a syringe inserted into a vial, with an arrow indicating a downward motion. The figure is labeled 'Figure E.' This likely depicts part of the medication preparation process for the GLUCAGON kit by Lupin Pharmaceuticals.*
FDA Label Image

Emergency Kit Label (8b4c72aa 10a8 4242 93bf E067d6d56f9a 09)

Emergency Kit Label (8b4c72aa 10a8 4242 93bf E067d6d56f9a 09)
Glucagon Emergency Kit for Low Blood Sugar contains Glucagon for Injection USP, 1 mg per vial, and a 1 mL syringe of diluent. The label instructs to reconstitute vial contents with the diluent. It is manufactured for Lupin Pharmaceuticals, Inc. and Lupin Limited, with storage instructions and usage warnings included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.